J&J's (JNJ) Janssen unit marketed its Risperdal drug to children in 2004 even though the FDA...
J&J's (JNJ) Janssen unit marketed its Risperdal drug to children in 2004 even though the FDA didn't approve such use until 2006, a company memo shows. The document was produced yesterday in a case in which Texas is suing J&J for $579M for defrauding the state's Medicaid scheme. The case is one of several J&J has been facing.
From other sites
at CNBC.com (Fri, 8:17AM)
Video at CNBC.com (Wed, 3:37PM)
Video at CNBC.com (Wed, 1:55PM)
at CNBC.com (Wed, 9:11AM)
Video at CNBC.com (Wed, 8:12AM)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs